Xanthocidin derivatives as topoisomerase IIα enzymatic inhibitors

Biol Pharm Bull. 2014;37(2):331-4. doi: 10.1248/bpb.b13-00757.

Abstract

Few studies have examined xanthocidin, a biotic isolated from Streptomyces xanthocidicus in 1966, because its supply is limited. Based on its chemical structure, xanthocidin has the potential to become a lead compound in the production of agrochemicals and anti-cancer drugs; however, it is unstable under both basic and acidic conditions. We recently established the total synthesis of xanthocidin using the FeCl3-mediated Nazarov reaction, and obtained two stable derivatives (#1 and #2). The results of the present study demonstrated that these derivatives exhibited the inhibitory activity of topoisomerase IIα, known as a molecular target for cancer chemotherapy, and this was attributed to the respective exo-methylene ketone group without DNA intercalation. The results obtained also suggest that these derivatives may have value as lead compounds in the synthesis of topoisomerase IIα inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacology*
  • Biological Products / pharmacology*
  • Cyclopentanes / pharmacology*
  • DNA Topoisomerases, Type II
  • DNA-Binding Proteins / antagonists & inhibitors*
  • Humans
  • Molecular Structure
  • Streptomyces / chemistry*
  • Topoisomerase II Inhibitors / chemical synthesis
  • Topoisomerase II Inhibitors / pharmacology*

Substances

  • Antigens, Neoplasm
  • Antineoplastic Agents
  • Biological Products
  • Cyclopentanes
  • DNA-Binding Proteins
  • Topoisomerase II Inhibitors
  • DNA Topoisomerases, Type II